Cancer drugs covered by WPA

Phone Us


Targeted/Biological therapies, when used for their European Medicines Agency (EMA) therapeutic indication, are covered by WPA, when these are not readily available to you as an NHS patient

In the past, any medication used to treat cancer was regarded as chemotherapy. However, over the last 20 years, new types of medication that work in a different way to chemotherapy have been introduced.

These new types of medication are known as targeted/biological therapies. This is because they are designed to target and disrupt one or more of the biological processes that cancerous cells use to grow and reproduce. In contrast, chemotherapy medications are designed to have a poisonous effect on cancerous cells.

Targeted/biological therapies, when used for their European Medicines Agency (EMA) therapeutic indication, are covered by WPA, when these are not readily available to you as an NHS patient (but some group schemes may vary).

If you visit your Cancer Specialist and are prescribed one of these targeted drugs, your Oncologist will be able to advise you of their availability on the NHS or the Cancer Drugs Fund (England). You can check whether your drug treatment is licensed by EMA for your cancer on www.ema.europa.eu and/or the NHS status of your drug on www.nice.org.uk, www.england.nhs.uk or www.scottishmedicines.org.uk - however we will be happy to advise you on your specific case.

We have provided a list of brand and generic names of commonly used targeted/biological therapies below; however, if you are not sure whether your treatment includes a targeted/biological therapy please contact us.

If you have any questions regarding the provision of benefit for any aspects of your treatment, please contact us to discuss the benefit that can be provided prior to any treatment commencing.

Please click here for examples of the Cancer Care available through WPA Policies.

Please click here for WPA´s current oncology schedule.


Last updated: 01/07/2017


Brand name Generic name   Brand name Generic name
Adcetris Brentuximab Vedotin   Afinitor Everolimus
Arzerra Ofatumumab   Avastin Bevacizumab
Bexxar Iodine 133-Tositumomab   Bosulif Bosutinib
Cabozantinib Cabometyx   Caprelsa Vandetanib
Ceritinib Zykadia   Cimzia Certolizumab
Cyramza Ramucirumab   Darzalex Daratumumab
Entyvio Vedolizumab   Erbitux Cetuximab
Eylea Aflibercept   Gazyvaro Obinutuzumab
Giotrif Afatinib   Glivec Imatinib
Herceptin Trastuzumab   Humira Adalimumab
Ibrance Palbociclib   Imbruvica Ibrutinib
Imlygic Talimogene Laherparepvec   Imnovid Pomalidomide
Inylta Axitinib   Kadcyla Trastuzumab Emtansine
Keytruda Pembrolizumab   Kyprolis Carfilzomib
Lartruvo Olaratumab   Lenvima/Kisplyx Lenvatinib
Lucentis Ranibizumab   Lynparza Olaparib
MabCampath Alemtuzumab   Mabthera Rituximab
Macugen Pegaptanib   Mekinist Trametinib
Mylotarg Gemtuzumab   Nexavar Sorafenib
Ninlaro Ixazomib   Opdivo Nivolumab
Perjeta Pertuzumab   Pomalyst Pomalidomide
Prolia Denosumab   Raptiva Efalizumab
Remicade Infliximab   Revlimid Lenalidomide
Ribociclib Kisqali   RoActemra Tocilizumab
Soliris Eculizumab   Sprycel Dasatinib
Stivarga Regorafenib   Sutent Sunitinib
Tafinlar Dabrafenib   Tagrisso Osimertinib
Tarceva Erlotinib   Tasigna Nilotinib
Tivozanib Fotivda   Tyverb Lapatanib
Vargatef Nintedanib   Vectibix Panitumumab
Velcade Bortezomib   Votrient Pazopanib
Votubia Everolimus   Yervoy Ipilimumab
Xalkori Crizotinib   Xgeva Denosumab
Xtandi Enzalutamide   Zaltrap Aflibercept
Zelboraf Vemurafenib   Zevalin Ibritumomab
Zytiga Abiraterone  


Please click here to view useful medical website links.